Portfolio Expansion ARBOR ASSAYS has an expanding DetectX catalog with recent launches including TXB2 ELISA, mouse TNF-alpha ELISA, BNP ELISA, and prior SARS-CoV-2 IgG kits, signaling ongoing demand for cardiovascular, immune, and infectious disease assays that can be cross-sold to existing customers.

Academic & Research Focus With a mission centered on supporting researchers worldwide and a history of collaboration (e.g., ISWE partnership), there is a strong opportunity to position bundled assay solutions, technical support packages, and volume-based pricing to universities, contract research organizations, and nonprofit labs.

Global Customer Service As an employee-owned company emphasizing quality and customer service, there is potential to differentiate via premium post-sale support, assay validation services, and rapid-response technical assistance to strengthen long-term sourcing relationships.

Technology & Reach A tech stack leveraging Google Ads, HubSpot analytics, and content management suggests readiness for targeted demand generation and inbound marketing; sales opportunities exist in converting website interest into trials or pilot programs for newDetectX kits.

SMB Growth Channel Revenue in the 10–25M range with a lean employee base indicates a scalable, adoptable product line for small to mid-size research labs; focus on tiered pricing, sampling programs, and regional distributors to accelerate adoption among smaller labs and regional biotech startups.